CRSP stock

Finance

why CRISPR Therapeutics AG [CRSP] is a Good Choice for Investors After New Price Target of $77.21

CRISPR Therapeutics AG [NASDAQ: CRSP] traded at a high on 2025-06-19, posting a 2.87 gain after which it closed the day’ session at $44.43. The results of the trading session contributed to over 5691441 shares changing hands. Over the past one week, the price volatility

Companies

Market Analysts see CRISPR Therapeutics AG [CRSP] gaining to $99. Time to buy?

CRISPR Therapeutics AG [NASDAQ: CRSP] stock went on a downward path that fall over -11.86% on Tuesday, amounting to a one-week price decrease of less than -11.34%. Over the last 12 months, CRSP stock dropped by -39.79%. The one-year CRISPR Therapeutics AG stock forecast points

CRSP stock

why CRISPR Therapeutics AG [CRSP] is a Good Choice for Investors After New Price Target of $77.21

Market Analysts see CRISPR Therapeutics AG [CRSP] gaining to $99. Time to buy?

Quick Links

Categories

Get The Best Stocks To Trade Every Day!